16:47 IST
BSE
Annual Report
Amerise Biosciences Annual Report
Amerise Biosciences has submitted its Annual Report for the financial year 2024-25. The company scheduled its 41st Annual General Meeting for September 24, 2026.
Amerise Biosciences Ltd
- Share price
- ₹0.82
- Market cap
- ₹5.42 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹0.02 Cr
- P/E (TTM)
- -102.6×Sector 28.6×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Capital Structure Change 4Other Announcement 3Financial Results 3Acquisition 3Management Change 2Board Meeting Date 2Annual General Meeting 2Annual Report 1
Time
1 announcement with these filters